Sugi Predict

Sugi Predict / Compounds / SCHEMBL25819509

SCHEMBL25819509

SCHEMBL25819509

O=C1CCN(c2ccc(N3CCC(CN4CCC5(CC4)CC(NC(=O)OCc4ccccc4)C5)CC3)cc2)C(=O)N1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRM4 P08173 3/20 0.44
▸ ENPP2 Q13822 2/20 0.40
▸ ATXN2 Q99700 2/20 0.40
▸ DDB1 Q16531 2/20 0.39
▸ CRBN Q96SW2 2/20 0.39
▸ CTSL P07711 1/20 0.39
▸ CTSB P07858 1/20 0.39
▸ CTSK P43235 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ MEN1 O00255 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ GPR55 Q9Y2T6 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ ITGB3 P05106 1/20 0.37
▸ ITGA2B P08514 1/20 0.37
▸ ME3 Q16798 1/20 0.37
▸ TLR4 O00206 1/20 0.37
▸ DPP4 P27487 2/20 0.36
▸ KCNH2 Q12809 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30135969 0.93 CHRM4 (0.42) CHRM4ENPP2ATXN2DDB1CRBN
SCHEMBL25819512 0.88 CHRM4 (0.48) CHRM4ENPP2ATXN2CTSLCTSB
SCHEMBL25302722 0.86 CRBN (0.39) CHRM4DDB1CRBNALDH1A1ITGB3
SCHEMBL30135868 0.86 DDB1 (0.43) CHRM4ENPP2ATXN2DDB1CRBN
SCHEMBL25819513 0.84 CHRM4 (0.44) CHRM4CTSLCTSBCTSKALDH1A1
SCHEMBL30135714 0.83 ENPP2 (0.38) CHRM4ENPP2ATXN2DDB1CRBN
SCHEMBL25819559 0.83 ENPP2 (0.38) CHRM4ENPP2ATXN2DDB1CRBN
SCHEMBL25819521 0.83 CHRM4 (0.45) CHRM4ENPP2ATXN2CTSLCTSB
SCHEMBL30965642 0.82 CHRM4 (0.44) CHRM4ENPP2ATXN2CTSLCTSB
SCHEMBL25819511 0.82 CHRM4 (0.44) CHRM4ENPP2ATXN2CTSLCTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11912710-B2 Substituted pyrimido[4,5-b][1,4]diazepines as PLK1 degradation inducers UPPTHERA, INC. (KR) 2024-02-27 — — US disclosed
US-11912710-B2 Substituted pyrimido[4,5-b][1,4]diazepines as PLK1 degradation inducers UPPTHERA, INC. (KR) 2024-02-27 — — US disclosed
US-20230219966-A1 NOVEL PLK1 DEGRADATION INDUCING COMPOUND UPPTHERA, INC. (KR) 2023-07-13 — — US disclosed
US-20230219966-A1 NOVEL PLK1 DEGRADATION INDUCING COMPOUND UPPTHERA, INC. (KR) 2023-07-13 — — US disclosed
EP-4157849-A1 NOVEL PLK1 DEGRADATION INDUCING COMPOUND Uppthera, Inc. (KR) 2023-04-05 — — EP disclosed
WO-2023017446-A1 NOVEL PLK1 DEGRADATION INDUCING COMPOUND UPPTHERA, INC. (KR) 2023-02-16 — — WO disclosed
WO-2023018238-A1 NOVEL PLK1 DEGRADATION INDUCING COMPOUND UPPTHERA, INC. (KR) 2023-02-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219966-A1 NOVEL PLK1 DEGRADATION INDUCING COMPOUND PLK1, BUB1B, BUB1 CHRM4 4481/4885ENPP2 1565/4885ATXN2 2262/4885
US-11912710-B2 Substituted pyrimido[4,5-b][1,4]diazepines as PLK1 degradation inducers PLK1, BUB1B, BUB1 CHRM4 4192/4885ENPP2 2034/4885ATXN2 1927/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.